FISCHERMedical Equipment & Supplies
Fischer Medical Ventures Ltd — Profit & Loss Statement
₹40.50
+4.84%
Fischer Medical Ventures Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Tax Rate For Calcs | 0.30 | 0.13 | 0.30 | 0.30 | — |
| Normalized EBITDA | 4.32 Cr | 2.36 Cr | 0.02 Cr | -0.19 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operation Net Minority Interest | 1.21 Cr | 1.84 Cr | -0.04 Cr | -0.23 Cr | — |
| Reconciled Depreciation | 0.80 Cr | 0.18 Cr | 0.00 | — | 0.00 |
| Reconciled Cost Of Revenue | 91.59 Cr | 16.45 Cr | 0.00 | — | 0.00 |
| EBITDA | 4.32 Cr | 2.36 Cr | 0.02 Cr | -0.19 Cr | — |
| EBIT | 2.69 Cr | 2.18 Cr | 0.02 Cr | -0.19 Cr | — |
| Net Interest Income | -0.47 Cr | -0.07 Cr | -0.02 Cr | -87000.00 | — |
| Interest Expense | 0.47 Cr | 0.07 Cr | 0.02 Cr | 87000.00 | — |
| Normalized Income | 1.21 Cr | 1.84 Cr | -0.04 Cr | -0.23 Cr | — |
| Net Income From Continuing And Discontinued Operation | 1.21 Cr | 1.84 Cr | -0.04 Cr | -0.23 Cr | — |
| Total Expenses | 109.01 Cr | 19.30 Cr | 0.16 Cr | 0.19 Cr | — |
| Diluted Average Shares | 5.49 Cr | 1.70 Cr | 0.02 Cr | 0.02 Cr | — |
| Basic Average Shares | 5.49 Cr | 1.11 Cr | 0.02 Cr | 0.02 Cr | — |
| Diluted EPS | 0.22 | 1.08 | -2.12 | -13.52 | — |
| Basic EPS | 0.22 | 1.65 | -2.12 | -13.52 | — |
| Diluted NI Availto Com Stockholders | 1.21 Cr | 1.84 Cr | -0.04 Cr | -0.23 Cr | — |
| Net Income Common Stockholders | 1.21 Cr | 1.84 Cr | -0.04 Cr | -0.23 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 1.21 Cr | 1.84 Cr | -0.04 Cr | -0.23 Cr | — |
| Net Income Including Noncontrolling Interests | 1.21 Cr | 1.84 Cr | -0.04 Cr | -0.23 Cr | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 1.21 Cr | 1.84 Cr | -0.04 Cr | -0.23 Cr | — |
| Tax Provision | 1.01 Cr | 0.27 Cr | 0.04 Cr | 0.04 Cr | — |
| Pretax Income | 2.22 Cr | 2.11 Cr | -13000.00 | -0.20 Cr | — |
| Other Non Operating Income Expenses | 1.49 Cr | 0.50 Cr | — | — | — |
| Special Income Charges | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Non Operating Interest Income Expense | -0.47 Cr | -0.07 Cr | -0.02 Cr | -87000.00 | — |
| Interest Expense Non Operating | 0.47 Cr | 0.07 Cr | 0.02 Cr | 87000.00 | — |
| Operating Income | 1.68 Cr | 1.68 Cr | 0.02 Cr | -0.19 Cr | — |
| Operating Expense | 17.43 Cr | 2.85 Cr | 0.16 Cr | 0.19 Cr | — |
| Other Operating Expenses | 13.21 Cr | 2.29 Cr | 0.06 Cr | 0.06 Cr | — |
| Depreciation And Amortization In Income Statement | 1.63 Cr | 0.18 Cr | 0.00 | — | 0.00 |
| Depreciation Income Statement | 1.63 Cr | 0.18 Cr | 0.00 | — | 0.00 |
| Gross Profit | 19.11 Cr | 4.53 Cr | 0.18 Cr | — | 0.17 Cr |
| Cost Of Revenue | 91.59 Cr | 16.45 Cr | 0.00 | — | 0.00 |
| Total Revenue | 110.70 Cr | 20.98 Cr | 0.18 Cr | 0.00 | — |
| Operating Revenue | 110.70 Cr | 20.98 Cr | 0.18 Cr | 0.00 | — |
| Interest Income | — | 0.50 Cr | 0.00 | — | — |
| Rent Expense Supplemental | — | 0.09 Cr | 0.02 Cr | 0.01 Cr | 99000.00 |
| Other Special Charges | — | -0.02 Cr | — | — | — |
| Interest Income Non Operating | — | 0.50 Cr | 0.00 | — | — |
| Selling General And Administration | — | 0.58 Cr | 0.04 Cr | 0.02 Cr | 91000.00 |
| Selling And Marketing Expense | — | 0.06 Cr | 0.00 | — | — |
| General And Administrative Expense | — | 0.52 Cr | 0.04 Cr | 0.02 Cr | 91000.00 |
| Rent And Landing Fees | — | 0.09 Cr | 0.02 Cr | 0.01 Cr | 99000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Fischer Medical Ventures Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.